Literature DB >> 2889393

[Intravenous anesthetics and human neutrophil granulocyte motility in vitro].

H G Kress1, R Segmüller.   

Abstract

Polymorphonuclear leukocytes (PMN) form a major part of the body's nonspecific first line of defense. An early event, prerequisite for the effective restriction of microbial invasions, is the chemotactic movement of activated neutrophils towards the invading organisms. To date, only limited and contradictory data exist regarding the effects of various intravenous anesthetic agents on neutrophil migration. In this study, the influence of ketamine, etomidate, midazolam, diazepam, and six commonly used i.v. barbiturates (hexo-, pheno-, pentobarbital, methohexital, thiopental, thiobutobarbital) on the in vitro motility of isolated human PMN was tested. Purified PMN (greater than 95%) were obtained from venous blood samples of healthy adults by dextran sedimentation, subsequent ammonium chloride treatment for red blood cell lysis, and Ficoll-Hypaque gradient centrifugation. Random and chemotactic migration were assessed under 1% agarose in the presence of 10(-3)-10(-7) M logarithmic dilutions of the agents in antibiotic free migration medium (MEM). N-fMet-Leu-Phe (FMLP) served as the standardized chemical attractant (10(-7) M). PMN motility was unaffected by ketamine and etomidate, but a significant (P less than 0.001), dose - related depression could be observed with both benzodiazepines at concentrations exceeding 10(-5) M (Fig. 1). Except at 10(-3) M concentration, this migratory inhibition proved to be easily reversible (Fig. 3). At the highest concentration tested (10(-3) M), all the barbiturates caused a significant (P less than 0.001) but completely reversible depression of random as well as chemotactic PMN migration (Table 1).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2889393

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  5 in total

1.  A randomized trial for the treatment of refractory status epilepticus.

Authors:  Andrea O Rossetti; Tracey A Milligan; Serge Vulliémoz; Costas Michaelides; Manuel Bertschi; Jong Woo Lee
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

2.  Observed medical and surgical complications of prolonged barbiturate coma for refractory status epilepticus.

Authors:  Christopher R Newey; Dolora Wisco; Premkumar Nattanmai; Aarti Sarwal
Journal:  Ther Adv Drug Saf       Date:  2016-07-18

3.  Calculating the risk benefit equation for aggressive treatment of non-convulsive status epilepticus.

Authors:  Matthew Ferguson; Matt T Bianchi; Raoul Sutter; Eric S Rosenthal; Sydney S Cash; Peter W Kaplan; M Brandon Westover
Journal:  Neurocrit Care       Date:  2013-04       Impact factor: 3.210

4.  The influence of intravenous anaesthetics on polymorphonuclear leukocyte function.

Authors:  W Krumholz; C Demel; S Jung; G Meuthen; G Hempelmann
Journal:  Can J Anaesth       Date:  1993-08       Impact factor: 5.063

5.  Thiopental inhibits migration of human leukocytes through human endothelial cell monolayers in vitro.

Authors:  R Hofbauer; D Moser; H Salfinger; M Frass; S Kapiotis
Journal:  Intensive Care Med       Date:  1998-09       Impact factor: 17.440

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.